Gene · 2621
NIH grants2,018
NIH grants whose papers are about the gene, through NIH's grant-paper links.
961 to 980 of 2,018
Download this page as JSON| Grant | Title | GAS6 papers | Newest fiscal year |
|---|---|---|---|
| R03NS116301 | Chronic Neurodegenerative Sequelae Driven by Neuroinflammation After Mild TBI | 1 | 2020 |
| R03TR003308 | Targeting understudied kinases in cancer cell plasticity and drug resistance | 1 | 2020 |
| R21AI146690 | Mechanisms of Cardioprotection by the Innate Immune System During Influenza Virus Infections | 1 | 2020 |
| R21AR074902 | Transcriptional Signature of Macrophages in SSc | 1 | 2020 |
| R21CA223400 | scFvPD1-FLT3 CAR T Cells for the Treatment of Relapsed Acute Myeloid Leukemia | 1 | 2020 |
| R21CA228187 | Targeting asymmetric ciliary signaling in cancer | 1 | 2020 |
| R21CA231252 | Oncogenic Synapses: cell-cell contacts enabling trogocytic-based metabolic interactions between pancreatic cancer and fibroblastic stromal cells | 1 | 2020 |
| R21CA234665 | Evaluation of PAK inhibitors towards targeting adaptive mechanisms of resistance in high-risk rhabdomyosarcoma | 1 | 2020 |
| R21CA235092 | Drug susceptibilities in fusion oncogene-driven pediatric sarcomas | 1 | 2020 |
| R21NS103841 | Analyzing Cell-Cell Fusion in Glioblastoma Growth and Progression | 1 | 2020 |
| R25GM079300 | Mentoring for Success: Developing Fundamental Skills for Biomedical Research | 1 | 2020 |
| R35CA197743 | Dissecting Pediatric Brain Tumor Microenvironment to Improve Treatment | 1 | 2020 |
| R50CA211252 | Investigating targeted degradation of c-Met to realize more effective cancer treatment | 1 | 2020 |
| R56AG066347 | MicroRNA-455-3p and Alzheimer's Disease | 1 | 2020 |
| RF1AG056318 | Capturing the molecular complexity of Alzheimer's disease through the lens of RNA binding proteins | 1 | 2020 |
| T32GM007062 | Mechanisms of Drug Action and Disposition | 1 | 2020 |
| T32GM007067 | Training Program in Cellular and Molecular Biology | 1 | 2020 |
| T32LM012412 | BIDS: Vanderbilt Training Program in BIg Biomedical Data Science | 1 | 2020 |
| T32MH073526 | Training Grant in Neurobehavioral Genetics | 1 | 2020 |
| U01AG018832 | Multicenter Osteoarthritis Study (MOST) Second Renewal: Iowa Clinical Center | 1 | 2020 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/grants?page=49